Fayez Sarofim & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-6,150
| Closed | -$204K | – | 246 |
|
|
2017
Q2 | $204K | Buy |
+6,150
| New | +$204K | ﹤0.01% | 238 |
|
|
2017
Q1 | – | Sell |
-6,150
| Closed | -$223K | – | 248 |
|
|
2016
Q4 | $223K | Hold |
6,150
| – | – | ﹤0.01% | 233 |
|
|
2016
Q3 | $283K | Hold |
6,150
| – | – | ﹤0.01% | 223 |
|
|
2016
Q2 | $309K | Hold |
6,150
| – | – | ﹤0.01% | 214 |
|
|
2016
Q1 | $329K | Hold |
6,150
| – | – | ﹤0.01% | 207 |
|
|
2015
Q4 | $404K | Hold |
6,150
| – | – | ﹤0.01% | 191 |
|
|
2015
Q3 | $347K | Hold |
6,150
| – | – | ﹤0.01% | 202 |
|
|
2015
Q2 | $363K | Hold |
6,150
| – | – | ﹤0.01% | 202 |
|
|
2015
Q1 | $383K | Hold |
6,150
| – | – | ﹤0.01% | 196 |
|
|
2014
Q4 | $354K | Hold |
6,150
| – | – | ﹤0.01% | 199 |
|
|
2014
Q3 | $331K | Hold |
6,150
| – | – | ﹤0.01% | 209 |
|
|
2014
Q2 | $322K | Hold |
6,150
| – | – | ﹤0.01% | 220 |
|
|
2014
Q1 | $325K | Sell |
6,150
-150
| -2% | -$7.93K | ﹤0.01% | 209 |
|
|
2013
Q4 | $253K | Buy |
+6,300
| New | +$253K | ﹤0.01% | 228 |
|
|
2013
Q2 | $241K | Buy |
+6,150
| New | +$241K | ﹤0.01% | 214 |
|